Skip to content

Prestige Consumer Healthcare PBH Additional Paid-In Capital

Additional Paid-In Capital at other companies

Procter & Gamble logo
Procter & GamblePG
$69.38B+1.1%
Bausch + Lomb logo
Bausch + LombBLCO
$8.58B+1.6%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$1.83B+49.6%
Organon logo
OrganonOGN
$186M+43.1%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$536.3M-1.7%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$656.44M-11.5%

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's additional paid-in capital?
Prestige Consumer Healthcare (PBH) reported additional paid-in capital of $608.52M in Q1 2026.
How has Prestige Consumer Healthcare's additional paid-in capital changed year-over-year?
Prestige Consumer Healthcare's additional paid-in capital increased by 2.5% year-over-year, from $593.4M to $608.52M.
What is the long-term trend for Prestige Consumer Healthcare's additional paid-in capital?
Over 5 years (2021 to 2026), Prestige Consumer Healthcare's additional paid-in capital has grown at a 4.0% compound annual growth rate (CAGR), from $499.51M to $608.52M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.